# Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer

> **NCT03661567** · PHASE2 · TERMINATED · sponsor: **Sun Yat-sen University** · enrollment: 52 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** chest radiation
- **DRUG:** concurrent chemotherapy
- **DRUG:** Methylprednisolone

## Key facts

- **NCT ID:** NCT03661567
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-09
- **Primary completion:** 2021-09-10
- **Final completion:** 2021-09-10
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** slow enrollment
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03661567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03661567, "Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03661567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*